NETARSUDIL

NETARSUDIL: Netarsudil is a medication used to treat glaucoma and intraocular hypertension. It is sold under the brand name Rhopressa.

The main mechanism of action of Netarsudil is through the inhibition of Rho kinase and norepinephrine transporter. Rho kinase inhibitors help to lower intraocular pressure by decreasing the resistance to aqueous humor outflow, while norepinephrine transporter inhibitors reduce the production of aqueous humor.

The recommended dosage of Netarsudil is one drop in the affected eye(s) once daily, preferably in the evening.

Common side effects of Netarsudil include ocular hyperemia (redness), eye itching, conjunctival hemorrhage (bleeding in the eye), blurred vision, corneal verticillata (whorl-like patterns on the cornea), and eye pain. Other less common side effects may include dryness, discharge, tearing, foreign body sensation, and increased sensitivity to light.

It is important to note that Netarsudil may cause changes in the pigmentation of the iris, eyelashes, and eyelids. These changes are usually reversible upon discontinuation of the medication. However, in rare cases, darkening of the iris may be permanent.

Some individuals may experience an allergic reaction to Netarsudil, characterized by swelling or itching of the face, lips, tongue, or throat, difficulty breathing, or hives. If any of these symptoms occur, immediate medical attention should be sought.

As with any medication, it is important to follow the prescribed dosage and inform your healthcare provider of any existing health conditions or medications you may be taking to prevent any potential interactions or adverse effects.